Bernard Denoyer
Director/Board Member at OKYO PHARMA LIMITED
Net worth: - $ as of 2024-05-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Gary Jacob | M | 77 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 21 years |
John Brancaccio | M | 76 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 20 years |
Gabriele Cerrone | M | 52 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 14 years |
Willy Simon | M | 72 | 9 years | |
Leslie M. Magnus | F | - | 9 years | |
Timothy Block | M | 69 | 11 years | |
Stephen Comiskey | M | - | 16 years | |
Raj Patil | M | 66 | 6 years | |
Keeren Shah | F | 47 | 4 years | |
Paul Spencer | M | - | 2 years | |
William Clementi | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Craig C. Talluto | M | - |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 8 years |
Christopher McGuigan | M | 65 | 3 years | |
Troy Hamilton | M | 52 | 4 years | |
Melvin Spigelman | M | 75 | 11 years | |
Johna Till Johnson | F | - |
META Group, Inc.
META Group, Inc. Miscellaneous Commercial ServicesCommercial Services META Group, Inc. provides research and analysis for information technology trends & markets. The firm's advisory services, which include research, on-site briefings, strategic plan reviews, phone consultations and conferences. It is specialized in enterprise architecture, e-commerce and global networking, as well as industry-specific programs. The company was founded in 1989 and is headquartered in Stamford, CT. | 4 years |
James Sapirstein | M | 63 | 4 years | |
Alan F. Joslyn | M | 65 | 10 years | |
Randall K. Johnson | M | 77 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 8 years |
Riccardo Dalla-Favera | M | 72 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 6 years |
Thomas H. Adams | M | 81 | 10 years | |
Timothy Sean Callahan | M | 53 | 4 years | |
Laura Barrow | M | - | - | |
Richard Daly | M | 62 | 3 years | |
Suzanne Starnes | F | - |
META Group, Inc.
META Group, Inc. Miscellaneous Commercial ServicesCommercial Services META Group, Inc. provides research and analysis for information technology trends & markets. The firm's advisory services, which include research, on-site briefings, strategic plan reviews, phone consultations and conferences. It is specialized in enterprise architecture, e-commerce and global networking, as well as industry-specific programs. The company was founded in 1989 and is headquartered in Stamford, CT. | 6 years |
Alberto Rossetti | M | - |
Columbia Business School
| 2 years |
Enrique R. Arzac | M | 82 |
Columbia Business School
| 44 years |
Marino Garcia | M | 57 | 4 years | |
Ernest Cuyegkeng | M | 77 |
Columbia Business School
| 2 years |
Carl Lehmann | M | - |
META Group, Inc.
META Group, Inc. Miscellaneous Commercial ServicesCommercial Services META Group, Inc. provides research and analysis for information technology trends & markets. The firm's advisory services, which include research, on-site briefings, strategic plan reviews, phone consultations and conferences. It is specialized in enterprise architecture, e-commerce and global networking, as well as industry-specific programs. The company was founded in 1989 and is headquartered in Stamford, CT. | 8 years |
Peter Trapp | M | - |
Columbia Business School
| 2 years |
Robert C. Shepard | M | - |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 7 years |
Len Amato | M | 74 |
Fairfield University
| 4 years |
Rafael F. Martínez-Margarida | M | 76 |
Fairfield University
| 4 years |
Salvatore Butera | M | 74 |
Fairfield University
| 4 years |
Patrick Griffin | M | 68 | 5 years | |
John p. DeBlasio | M | - |
META Group, Inc.
META Group, Inc. Miscellaneous Commercial ServicesCommercial Services META Group, Inc. provides research and analysis for information technology trends & markets. The firm's advisory services, which include research, on-site briefings, strategic plan reviews, phone consultations and conferences. It is specialized in enterprise architecture, e-commerce and global networking, as well as industry-specific programs. The company was founded in 1989 and is headquartered in Stamford, CT. | 2 years |
Gail M. Comer | M | - | - | |
William Hornung | M | 55 | 1 years | |
Chris Pattacini | M | - |
META Group, Inc.
META Group, Inc. Miscellaneous Commercial ServicesCommercial Services META Group, Inc. provides research and analysis for information technology trends & markets. The firm's advisory services, which include research, on-site briefings, strategic plan reviews, phone consultations and conferences. It is specialized in enterprise architecture, e-commerce and global networking, as well as industry-specific programs. The company was founded in 1989 and is headquartered in Stamford, CT. | 7 years |
Terry Horan | M | 73 |
Fairfield University
| 4 years |
Henry James Sandlass | M | - |
Columbia Business School
| 2 years |
James Dwyer | M | - |
Columbia Business School
| 2 years |
Dan Dunham | M | - | - | |
Bram Bluestein | M | - |
Columbia Business School
| 2 years |
Vaseem Palejwala | M | - | 5 years | |
Chhaya Shah | F | 60 | 3 years | |
Ann Frances Kaplan | F | - |
Columbia Business School
| 1 years |
Joseph F. Berardino | M | 73 |
Fairfield University
| 4 years |
Corey Ferengul | M | - |
META Group, Inc.
META Group, Inc. Miscellaneous Commercial ServicesCommercial Services META Group, Inc. provides research and analysis for information technology trends & markets. The firm's advisory services, which include research, on-site briefings, strategic plan reviews, phone consultations and conferences. It is specialized in enterprise architecture, e-commerce and global networking, as well as industry-specific programs. The company was founded in 1989 and is headquartered in Stamford, CT. | 5 years |
Christoph Bruening | M | 56 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 7 years |
Stephen K. Carter | M | 85 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 4 years |
Richard Perlman | M | 77 |
Columbia Business School
| 2 years |
Carol Einiger | F | 74 |
Columbia Business School
| 2 years |
Pamela A. Harris | M | - |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | - |
Joseph Bronson | M | 75 |
Fairfield University
| 4 years |
John T. Dillon | M | 85 |
Columbia Business School
| 2 years |
Willard Overlock | M | 78 |
Columbia Business School
| 2 years |
Francis Scricco | M | 74 |
Columbia Business School
| 2 years |
Paul Fulchino | M | 77 |
Columbia Business School
| 2 years |
Julian S. Inclán | M | 76 |
Columbia Business School
| 2 years |
Césareo Alierta Izuel | M | 79 |
Columbia Business School
| 15 years |
Iain Ross | M | 71 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | - |
George E. Dlugos | M | - |
Fairfield University
| 4 years |
Michael J. King | M | - |
META Group, Inc.
META Group, Inc. Miscellaneous Commercial ServicesCommercial Services META Group, Inc. provides research and analysis for information technology trends & markets. The firm's advisory services, which include research, on-site briefings, strategic plan reviews, phone consultations and conferences. It is specialized in enterprise architecture, e-commerce and global networking, as well as industry-specific programs. The company was founded in 1989 and is headquartered in Stamford, CT. | 4 years |
Mark S. Geraghty | M | - |
Fairfield University
| 4 years |
Donald Picker | M | 78 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 5 years |
Kunwar Shailubhai | M | 67 |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | 3 years |
Paolo Scaroni | M | 76 |
Columbia Business School
| 2 years |
Randolph I. Thornton | M | 78 |
Columbia Business School
| 2 years |
Harry O. Christenson | M | 80 |
Fairfield University
| 4 years |
Robert L. Natt | M | - |
Columbia Business School
| 1 years |
Anthony Grant Froggatt | M | 76 |
Columbia Business School
| 2 years |
Mortimer Berkowitz | M | 70 |
Columbia Business School
| 4 years |
Gary Sender | M | 62 | 1 years | |
Robert M. Mahoney | M | 75 |
Columbia Business School
| 2 years |
Gary Gemignani | M | 58 | 2 years | |
Sidney Taurel | M | 75 |
Columbia Business School
| 2 years |
Henry Stephen Miller | M | 78 |
Columbia Business School
| 2 years |
Nevin Ekici | F | - |
META Group, Inc.
META Group, Inc. Miscellaneous Commercial ServicesCommercial Services META Group, Inc. provides research and analysis for information technology trends & markets. The firm's advisory services, which include research, on-site briefings, strategic plan reviews, phone consultations and conferences. It is specialized in enterprise architecture, e-commerce and global networking, as well as industry-specific programs. The company was founded in 1989 and is headquartered in Stamford, CT. | - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 75 | 93.75% |
United Kingdom | 8 | 10.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Bernard Denoyer
- Personal Network